Martin Brenoe
Stock Analyst at Nordea Markets
(0.51)
# 4,006
Out of 4,407 analysts
10
Total ratings
20%
Success rate
-23.4%
Average return
Main Sectors:
Stocks Rated by Martin Brenoe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZLDPF Zealand Pharma A/S | Downgraded: Hold | n/a | $44.70 | - | 1 | Mar 6, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | n/a | $43.88 | - | 1 | Feb 24, 2026 | |
| WILLF Demant A/S | Upgraded: Buy | $52 → $36 | $35.45 | +0.69% | 3 | Feb 18, 2026 | |
| LON: 0NQC Pandora A/S | Upgraded: Buy | kr 300.00 → kr 1,200 | $647.61 | n/a | 3 | May 7, 2025 | |
| OSSFF Embla Medical hf. | Initiated Coverage: Buy | $5.87 | $4.15 | n/a | 1 | Jun 22, 2023 | |
| PNDRY Pandora A/S | Upgraded: Hold | n/a | $12.43 | n/a | 1 | Feb 9, 2023 |
Zealand Pharma A/S
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.70
Upside: -
Novo Nordisk
Feb 24, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.88
Upside: -
Demant A/S
Feb 18, 2026
Upgraded: Buy
Price Target: $52 → $36
Current: $35.45
Upside: +0.69%
Pandora A/S
May 7, 2025
Upgraded: Buy
Price Target: kr 300.00 → kr 1,200
Current: $647.61
Upside: n/a
Embla Medical hf.
Jun 22, 2023
Initiated Coverage: Buy
Price Target: $5.87
Current: $4.15
Upside: n/a
Pandora A/S
Feb 9, 2023
Upgraded: Hold
Price Target: n/a
Current: $12.43
Upside: n/a